Breathing in TB treatment: new inhaler trial seeks to fight lung infection

NCT ID NCT07073638

Recruiting now Disease control Sponsor: Thirty Respiratory Limited Source: ClinicalTrials.gov ↗

Summary

This study is testing a new inhaled treatment called RESP30TB for adults with newly diagnosed, drug-susceptible tuberculosis. Researchers want to see if breathing in this medicine is safe and if it starts killing TB bacteria in the lungs. The trial will enroll 24 participants to monitor side effects and measure early signs of effectiveness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

TASK Clinical Research Centre
RECRUITING

Cape Town, Bellville, 7531, South Africa

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PULMONARY TUBERCULOSES